Vaccine Transporters Feel Unprepared For The Distributive Effort Ahead

As pharmaceutical companies conduct phase 3 vaccine trials, air cargo transporters are cautious about the logistics involved in the mass distribution of a Covid-19 vaccine. A recent survey found that less than 30% of air cargo companies felt prepared for the job ahead. Developing the vaccine is only the first step. Getting that vaccine to the population will prove as difficult.

Vaccines are difficult to distribute in part because of their delicate structure. Most vaccines need to stay cool to maintain effectiveness. Moderna and Pfizer’s Covid-19 vaccine candidates need temperatures of -15 and -70 degrees Celsius. For reference, most flu vaccines are stored between 0 and -15 degrees Celsius. Shipping hundreds of millions of vaccines at -70 degrees Celsius would be an unprecedented distributive feat requiring thousands, if not millions of super cold transportation containers.

Read the full article on Forbes.

© William A. Haseltine, PhD. All Rights Reserved.